Medicus Pharma (MDCX) vs Soligenix (SNGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Soligenix is the larger company by market cap ($7.5 million vs $7.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDCX | SNGX |
|---|---|---|
| Share price | $0.1019 | $0.3466 |
| Market cap | $7.31M | $7.54M |
| 1-day change | -36.39% | -1.95% |
| YTD return | -93.34% | — |
| 1-year return | -95.86% | — |
| EPS (TTM) | $-2.38 | $-0.79 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.78 | $1.97 |
| 52-week low | $0.0941 | $0.28 |
| Distance from 52-week high | -96.33% | -82.41% |
| Analyst consensus | none | none |
| Avg. price target upside | +4316.09% | +298.15% |
| Average volume | 4.43M | 253.75K |
| Shares outstanding | 71.71M | 21.77M |
| Employees | 16 | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Healthcare · Drug Manufacturers - General · 16 employees
About Soligenix
SNGX stock →Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Healthcare · Biotechnology · 13 employees
MDCX vs SNGX FAQ
Which is bigger, Medicus Pharma or Soligenix?
Soligenix (SNGX) is larger, with a market capitalization of $7.54M compared with $7.31M for Medicus Pharma (MDCX).
Are Medicus Pharma and Soligenix in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - General for Medicus Pharma and Biotechnology for Soligenix.